Camila Coelho

One Gustave L. Levy Place
10029-6574 New York
United States

h-index

Research activity per year

Headline

ASSISTANT PROFESSOR | Microbiology

Fingerprint

Dive into the research topics where Camila Coelho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

34 Article
6 Comment/debate
3 Short survey
2 Review article
More

Monoclonal antibodies for Mpox: protective targets and therapeutic potential
Guardado-Calvo, P., Freund, N. T. & Coelho, C. H., Mar 2026, In: Current Opinion in HIV and AIDS. 21, 2, p. 118-124 7 p.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational study
Crandell, J., Fantin, R. F., de Araújo, L. P., Lawres, L., Pischel, L., Monteiro, V. S., Conde, L., Kottkamp, A. C., Samanovic, M. I., Cordeiro, R., Póvoas, D., Melo, M., Castineiras, T. M., Vale, A. M., Yildirim, I., Mulligan, M. J., de Almeida, L. A., Omer, S. B., Coelho, C. H. & Lucas, C., 2026, (Accepted/In press) In: The Lancet Infectious Diseases.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
The lasting lessons of mpox: infection, vaccination, and immune memory
Fantin, R. & Coelho, C. H., Feb 2026, In: The Lancet Infectious Diseases. 26, 2, p. 118-120 3 p.
Research output: Contribution to journal › Comment/debate

1 Scopus citations
The sweet truth about germinal centers
Rao, V. N., Silva, A. L. T. & Coelho, C. H., 2026, (Accepted/In press) In: Trends in Immunology.
Research output: Contribution to journal › Short survey › peer-review
Universal vaccines? Only if your antibody genes agree
Rao, V. N. & Coelho, C. H., 14 Apr 2026, In: Immunity. 59, 4, p. 940-942 3 p.
Research output: Contribution to journal › Article › peer-review

Researchers from University of California San Diego (UCSD) Detail Findings in COVID-19 (Impact of Covid-19 Monoclonal Antibody Therapy On Subsequent Vaccine-elicited Sars-cov-2 Immune Responses)
Coelho, C.
26/03/26
1 item of Media coverage
Press/Media
Mpox infection triggers stronger, longer-term protection than vaccination, study suggests Mary Van Beusekom
Coelho, C.
11/11/25
1 item of Media coverage
Press/Media
Findings from Icahn School of Medicine at Mount Sinai in the Area of Vaccines Described (Convergent and clonotype-enriched mutations in the light chain drive affinity maturation of a public antibody)
Bajic, G., Krammer, F., Simon, V. & Coelho, C.
26/09/25
1 item of Media coverage
Press/Media
Investigators at National Institute of Allergy and Infectious Diseases (NIAID) Zero in on Colitis (Giardia-induced Type 2 mucosal immunity attenuates intestinal inflammation caused by co-infection or colitis in mice)
Coelho, C.
19/09/25
1 item of Media coverage
Press/Media
Health Rounds: Nasal spray for allergies may help prevent COVID, common cold infections
Coelho, C.
9/09/25 → 10/09/25
7 items of Media coverage
Press/Media

Camila Coelho

Personal profile

Headline

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Monoclonal antibodies for Mpox: protective targets and therapeutic potential

Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational study

The lasting lessons of mpox: infection, vaccination, and immune memory

The sweet truth about germinal centers

Universal vaccines? Only if your antibody genes agree

Researchers from University of California San Diego (UCSD) Detail Findings in COVID-19 (Impact of Covid-19 Monoclonal Antibody Therapy On Subsequent Vaccine-elicited Sars-cov-2 Immune Responses)

Mpox infection triggers stronger, longer-term protection than vaccination, study suggests Mary Van Beusekom

Findings from Icahn School of Medicine at Mount Sinai in the Area of Vaccines Described (Convergent and clonotype-enriched mutations in the light chain drive affinity maturation of a public antibody)

Investigators at National Institute of Allergy and Infectious Diseases (NIAID) Zero in on Colitis (Giardia-induced Type 2 mucosal immunity attenuates intestinal inflammation caused by co-infection or colitis in mice)

Health Rounds: Nasal spray for allergies may help prevent COVID, common cold infections

Camila Coelho

Personal profile

Headline

Fingerprint

Collaborations and top research areas from the last five years

Research output

Press/Media